Cannabidiol Gvhd

Graft versus host disease (GVHD) is one of the major causes of death in patients undergoing allogeneic hematopoietic cell transplantation. Despite prophylactic. Graft versus Host Disease ("GVHD") – Kalytera Therapeutics, Inc. – Kalytera is developing a clinical-stage cannabidiol ("CBD") medicine to prevent and treat Graft versus Host Disease ("GvHD"). GvHD is a multisystem disorder. Graft-versus-host-disease (GVHD) is a major obstacle […]